Follow The Filings

DX Dynex Capital

Dynex Capital earnings company data as of 5:51 PM ET 10/23

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 19 Oct EPS 0.37 — —
Rev $113.0M — —

Insider trades

Open-market buys and sales by DX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DX insider trades
  • $269K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Byron L Boston CEO
    Buy
    $100K 9,180 shares at $10.89 +1% to stake
    Traded Oct 20 Filed Oct 21
    ↗
  2. Smriti Laxman Popenoe CEO
    Buy
    $106K 10,000 shares at $10.62 +1.9% to stake
    Traded Oct 20 Filed Oct 20
    ↗
  3. Michael Andrew Sartori CFO
    Buy
    $11K 1,000 shares at $10.70 +2.8% to stake
    Traded Oct 20 Filed Oct 20
    ↗
  4. Terrence John Connelly Jr. Chief Investment Officer
    Buy
    $28K 2,500 shares at $11.18 +4.4% to stake
    Traded Sep 25 Filed Sep 28
    ↗
  5. Smriti Laxman Popenoe CEO
    Buy
    $24K 2,000 shares at $12.19 +0.4% to stake
    Traded Feb 27 Filed Mar 30
    ↗

Also filed in the last 12 months, not counted as buying or selling: 11 stock grants, 9 share withholdings for taxes, and 1 trade in other securities.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
8-K 3.03,5.03,8.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02,5.03,5.07,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.